Overview

Changes of the Infusion Rate in Insulin Pump Treatment

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
A pharmacokinetic study of insulin pump treatment using Insulin Aspart. The study consist of three different periods A, B and C where a constant the insulin infusion rate is given during the periods. In period B and C will the infusion start with a bolus. It will be investigated if a steady state of insulin will be obtained faster in period B and C then A.
Phase:
Phase 4
Details
Lead Sponsor:
Aarhus University Hospital
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting